Two new bicyclic hexapeptides, RA-XXIII and RA-XXIV, were isolated from the roots of Rubia cordifolia L. (Rubiaceae). Their structures were determined by the analysis of their 2D NMR spectra, chemical methods, and X-ray crystallography. The IC 50 values of RA-XXIII and RA-XXIV against P-388 leukemia cells were 0.16 and 0.48 m mg/ml, respectively.
showing the most potent antitumor activity, was subjected to clinical trials in Japan as a possible potential anti-cancer drug in the 1980-90s.
3) Their antitumor action is considered to be due to inhibition of protein synthesis through interaction with eukaryotic ribosomes, 4, 5) and peptide 1 is known to cause conformational changes in F-actin and stabilization of actin filaments to induce G2 arrest. 6) In the present study, two new RA-series peptides, RA-XXIII (2) and RA-XXIV (3), were further isolated from the roots of R. cordifolia. This paper describes their isolation, structure determination, and cytotoxicity against P-388 cells.
A methanol extract obtained from dried roots of R. cordifolia (50 kg) was partitioned between chloroform and water. The chloroform-soluble portion was subjected to a series of column chromatography using silica gel, alumina, and then aminopropyl-bonded silica gel, eluting with a series of chloroform/methanol mixtures, to give a fraction rich in peptides of RAs. The residue of this fraction, obtained after removal of the solvent, was crystallized from methanol to give crystals of crude RAs and a mother liquor. The mother liquor afforded, after separation by reversed-phase HPLC (ODS) and subsequent crystallization from methanol, RA-XXIII (2, 141 mg, 2.8ϫ10 Ϫ4 %) and RA-XXIV (3, 281 mg, 5.6ϫ 10 Ϫ4 %). RA-XXIII (2) was obtained as colorless fine needles. Its molecular formula was determined to be C 43 C-NMR signals and NOE correlations due to the peptide backbone in 1 and 2 were very similar to each other, indicating that 1 and 2 shared the same relative configuration. These observations suggested that peptide 2 was an analogue of 1 whose Ala-2 was replaced by glutamine, which was verified by the preparation of peptide 2 by ammonolysis of RA-IX (4), another RA-series peptide obtained from the same plant source previously.
9) The structure of 2 was confirmed to be as shown in Fig. 1 by X-ray crystallography of bromide 2a derived from 2 (Fig. 3) . The absolute structure parameter (Flack parameter) was 0.040 with an esd of 0.012, which indicated that the absolute structure shown in the figure represents the correct enantiomer.
RA-XXIV (3) was obtained as colorless needles. Its molecular formula was determined to be C 42 H 51 N 7 O 10 from the [MϩH] ϩ peak at m/z 814.3829 (Calcd for C 42 H 52 N 7 O 10 , 814.3776) in the HR-ESI-MS. The 1 H-and 13 C-NMR spectra of 3 were very similar to those of 2, except that the 1 H-NMR spectrum of 3 had only one methoxyl signal with a newly appeared phenolic hydroxyl signal at d H 11.72. This phenolic hydroxyl signal showed a cross-peak with H-ea in the NOESY spectrum, thus indicating that in 3, a hydroxyl group substituted for the methoxyl group at the z-position of Tyr-6 in 2. A downfield shift of the 13 C-NMR signal for C-ea in Tyr-6, from d C 113.5 for 2 to d C 117.8 for 3, also explains the replacement of the O-methyl group by a hydroxyl group. Treatment of 3 with (trimethylsilyl)diazomethane afforded a product which was shown to be identical to natural 2 by their spectroscopic data and optical rotations. Thus, the absolute structure of 3 was determined to be as shown in Fig. 1 . Peptides 2 and 3 both showed moderate cytotoxicity against P-388 murine leukemia cells with IC 50 values of 0.16 and 0.48 mg/ml, respectively.
Experimental
General Experimental Procedures Melting points were determined on a Yanaco MP-3 apparatus and are recorded uncorrected. Optical rotations were measured on a JASCO P-1030 digital polarimeter, IR spectra on a JASCO FT/IR 620 spectrophotometer, and UV spectra on a JASCO V-530 spectrophotometer. NMR spectra were measured on a Bruker DRX-500 spectrometer at 300 K. The . Mass spectra were obtained with a Micromass LCT spectrometer. Single-crystal X-ray analysis was carried out on a Bruker AXS APEX II ULTRA CCD area detector diffractometer with a rotating anode source (MoKa radiation, lϭ0.71073 Å). Preparative HPLC was carried out on a Shimadzu LC-6AD pump unit equipped with a SPD-10A UV detector (l 254 nm) and a pre-packed ODS column (5 mm, 20ϫ250 mm), eluting with a MeOH/H 2 O mixture at a flow rate of 10 ml/min.
Plant Material The roots of Rubia cordifolia L. were commercially obtained in Tokyo in March 2004. The material was identified by Prof. Koichi Takeya, and a voucher specimen (Tko-0403-01) has been deposited at the Herbarium of Tokyo University of Pharmacy and Life Sciences.
Extraction and Isolation The dried roots (50 kg) of R. cordifolia was extracted with MeOH (3ϫ175 l). After removal of MeOH under reduced pressure, the residue (3.6 kg) was partitioned between chloroform and water.
The chloroform-soluble portion (993 g) was placed on a column of silica gel (Merck, 70-230 mesh, 3.6 kg) and eluted with CHCl 3 (9 l), EtOAc (18 l), and CHCl 3 /MeOH (9 : 1, 27 l), sequentially to give three fractions. After removal of the solvent, the residue of the CHCl 3 /MeOH (9 : 1) fraction (152 g) was subjected to alumina (Merck, 3 kg) column chromatography (CC) eluting sequentially with CHCl 3 (2 l) and CHCl 3 /MeOH (9 : 1, 12 l). After evaporation, the CHCl 3 /MeOH (9 : 1) fraction (41.9 g) was subjected to aminopropyl-bonded silica gel (Chromatorex, 200-350 mesh, 300 g) CC eluting sequentially with CHCl 3 (6 l) and CHCl 3 /MeOH (9 : 1, 1 l). The residue obtained after removal of the solvent of the CHCl 3 /MeOH (9 : 1) eluate was crystallized from methanol to give crystals of crude RAs (2.4 g) and mother liquor (ML). After removal of the solvent, ML (6.2 g) was subjected to ODS HPLC (MeOH/H 2 O 60 : 40) to give four fractions, F1 (0.52 g), F2 (1.07 g), F3 (0.31 g), and F4 (0.17 g). F1 and F3 were each crystallized from methanol to give RA-XXIV (3) H-and 13 C-NMR spectra, mass spectra, and optical rotations.
Bromination of 2 Pyridinium hydrobromide perbromide (ca. 85% purity, 13.7 mg, 0.0364 mmol) and sodium acetate (3.0 mg, 0.037 mmol) were added to a solution of 2 (20.1 mg, 0.0243 mmol) in MeOH/EtOAc (1 : 1, 1 ml) at 0°C. The mixture was stirred at 0°C for 1 h, and then at room temperature for 16 h. The mixture was diluted with chloroform (20 ml), washed sequentially with 5% aqueous sodium sulfite (5 ml) and brine (10 ml), dried over MgSO 4 , and filtered. The solvent was removed under reduced pressure, and the residue was separated by ODS HPLC (MeOH/H 2 O 35 : 65) to afford 2a (15.7 mg, 71%) as colorless needles, mp 256-259°C (MeOH).
1 H-NMR (500 MHz, pyridine-d 5 C-NMR spectra, mass spectra, and optical rotations.
Assay for Cytotoxic Activity The MTT (3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyltetrazolium bromide) colorimetric assay was performed on a 96-well plate. Murine P-388 leukemia cells (3ϫ10 3 cells) in 100 ml of RPMI-1640 medium (Nissui Pharmaceutical Co., Ltd., Tokyo, Japan) supplemented with 5% fetal calf serum (Mitsubishi Chemical Industry Co., Ltd., Tokyo, Japan) and kanamycin (100 mg/ml) were placed into each well and incubated at 37°C in a humidified atmosphere of 7% CO 2 . After 24 h incubation, samples of test compounds at various concentrations (10 ml) were added to the cultures, and the mixtures were incubated for 48 h at 37°C. Then, 20 ml of an MTT solution (5 mg/ml) was added to each well. After a further incubation for 4 h, 100 ml of 10% sodium dodecyl sulfate-0.01 M HCl solution was added to each well and the formazan crystals formed in each well were dissolved by stirring with a pipette. Optical density was recorded on a microplate reader (Tosoh MPR-A4i) at 550 nm. The cytotoxic activities represent the average of three replicate measurements for each test.
